NASDAQ · CMPSHealthcarePharmaceuticals

COMPASS Pathways Plc American Depository Shares financials

$12.96−2.04%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
FY20
Dec 31
Revenue$0.00$0.00$0.00$0.00$0.00—
Gross profit$0.00$0.00$0.00$0.00$0.00—
Gross margin——————
Operating income-$179.0M-$178.2M-$136.9M-$110.4M-$83.2M-$51.4M
Net income-$287.9M-$155.1M-$118.5M-$91.5M-$71.7M-$60.3M
Net margin——————
Diluted EPS$-3.08$-2.30$-2.32$-2.16$-1.79$-3.55
EBITDA-$178.8M-$178.0M-$136.7M-$107.9M-$81.2M-$51.3M
Operating cash flow-$157.2M-$119.2M-$97.4M-$105.5M-$67.7M-$41.4M
Free cash flow-$157.2M-$119.2M-$97.4M-$106.0M-$68.1M-$41.5M
Diluted shares93.5M67.5M51.0M42.4M40.0M17.0M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$149.6M$165.1M$220.2M$143.2M$273.2M$190.3M
Short-term investments$0.00$0.00$0.00$0.00——
Total debt$31.6M$30.2M$28.8M$0.00$0.00$0.00
Total assets$210.3M$213.7M$276.0M$197.3M$300.9M$203.5M
Total liabilities$263.2M$59.0M$50.2M$16.0M$16.5M$6.9M
Shareholders' equity-$52.8M$154.7M$225.7M$181.3M$284.4M$196.6M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology